{
  "meta": {
    "title": "Mid_Day_Module_Medicine-11",
    "url": "https://brainandscalpel.vercel.app/mid-day-module-medicine-11-39fe4277.html",
    "scrapedAt": "2025-11-29T18:15:14.183Z"
  },
  "questions": [
    {
      "id": 49305,
      "choices": [
        {
          "id": 196787,
          "text": "<p>Transferrin</p>"
        },
        {
          "id": 196788,
          "text": "<p>Ceruloplasmin</p>"
        },
        {
          "id": 196789,
          "text": "<p>Albumin</p>"
        },
        {
          "id": 196790,
          "text": "<p>Fibrinogen</p>"
        }
      ],
      "text": "<p>Which of the following is not decreased in Nephrotic Syndrome? (NEET PG 2015)</p>",
      "unique_key": "Q4202340",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833756,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: D. Fibrinogen</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Nephrotic syndrome is characterized by increased glomerular permeability resulting in heavy proteinuria (&gt;3.5g/day), leading to hypoalbuminemia, hyperlipidemia, and edema. In this condition, there is significant urinary loss of proteins, particularly those with smaller molecular weight. However, fibrinogen is not decreased in nephrotic syndrome - it is actually increased as part of the acute phase response and due to increased hepatic synthesis.</p><p>&nbsp;</p><p><strong>&nbsp;Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Transferrin:&nbsp;</strong>Transferrin is decreased in nephrotic syndrome. Nephrotic syndrome leads to significant urinary loss of proteins, including transferrin, which has a molecular weight smaller than albumin, making it readily filtered through damaged glomeruli.</p><p>&nbsp;</p><p><strong>Option B. Ceruloplasmin:&nbsp;</strong>&nbsp;Ceruloplasmin levels are decreased in nephrotic syndrome due to urinary losses similar to other plasma proteins that are filtered through the damaged glomerular filtration barrier.</p><p>&nbsp;</p><p><strong>Option C. Albumin:&nbsp;</strong>&nbsp;Albumin is significantly decreased in nephrotic syndrome. Hypoalbuminemia is a cardinal feature of nephrotic syndrome, resulting from urinary protein losses exceeding the liver's capacity to synthesize new albumin.</p><p>&nbsp;</p><p><strong>Option D. Fibrinogen:</strong> Fibrinogen is not decreased but actually elevated in nephrotic syndrome. This occurs as part of the acute phase response and due to increased hepatic synthesis that compensates for the loss of other proteins. The larger molecular weight of fibrinogen also makes it less likely to be filtered through the damaged glomeruli.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nephrotic syndrome results in decreased levels of many plasma proteins (including albumin, transferrin, and ceruloplasmin) due to urinary losses, but fibrinogen levels are typically increased due to compensatory hepatic synthesis and its larger molecular size, contributing to the hypercoagulable state often seen in these patients.</span></p>",
      "correct_choice_id": 196790,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54288,
      "choices": [
        {
          "id": 216621,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory Acidosis</span></p>"
        },
        {
          "id": 216622,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory Alkalosis</span></p>"
        },
        {
          "id": 216623,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic Acidosis</span></p>"
        },
        {
          "id": 216624,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic Alkalosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old male presents to the clinic with complaints of nausea, diarrhea, and vomiting. Upon further investigation, arterial blood gas (ABG) analysis reveals the following: pH: 7.55, PCO2: 50 mmHg, HCO3-: 44 mmol/L. Given these findings, which of the following conditions is the most likely diagnosis?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7762794",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833751,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Metabolic Alkalosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ABG analysis reveals a pH of 7.55, indicating alkalosis (normal pH range: 7.35-7.45). The elevated bicarbonate (HCO3-) level of 44 mmol/L (normal range: 22-28 mmol/L) points towards a metabolic origin for the alkalosis. In metabolic alkalosis, the kidneys retain bicarbonate, leading to an increase in serum bicarbonate levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Additionally, the elevated PCO2 (partial pressure of carbon dioxide) of 50 mmHg (normal range: 35-45 mmHg) indicates a compensatory respiratory response. In metabolic alkalosis, the body attempts to compensate by hypoventilation, which increases PCO2 to counteract the rise in pH.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>pH 7.55</strong>: Indicates alkalosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>PCO2 50 mmHg</strong>: Elevated, indicating respiratory compensation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>HCO3- 44 mmol/L</strong>: Elevated, indicating a metabolic cause.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Respiratory Acidosis</strong>: This condition is characterized by a low pH and high PCO2 due to impaired ventilation, resulting in CO2 retention. The pH would be acidic, not alkalotic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Respiratory Alkalosis</strong>: This condition involves a high pH and low PCO2 due to hyperventilation. However, in this case, PCO2 is elevated, not decreased.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Metabolic Acidosis</strong>: This condition involves a low pH and low bicarbonate levels due to an accumulation of acid or loss of bicarbonate. The pH here is alkalotic, not acidic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metabolic alkalosis is characterized by an elevated pH and bicarbonate level, with respiratory compensation leading to increased PCO2.</span></p>",
      "correct_choice_id": 216624,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54288/INI-CET_May_2024Medicine_Question_33.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54288/INI-CET_May_2024Medicine_Question_33.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59291,
      "choices": [
        {
          "id": 236477,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroid receptor antibody</span></span></p>"
        },
        {
          "id": 236478,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Thyroglobulin Antibody</span></span></p>"
        },
        {
          "id": 236479,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasensitive thyrotropin</span></span></p>"
        },
        {
          "id": 236480,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-thyroid peroxidase antibody</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 23-year-old medical student with a 2-month history of palpitations, sweating, restlessness, and sweaty palms. Which of the following will help in diagnosis? (FMGE JUNE 2022)</span></span></span></p>",
      "unique_key": "Q3648874",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833765,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Ultrasensitive thyrotropin</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The initial test for evaluating thyroid disorders, including hyperthyroidism, is the measurement of TSH (thyrotropin). An ultrasensitive TSH assay is the first step in diagnosing thyroid dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Thyroid receptor antibody:</span></strong><span style=\"font-size:12.0pt\"> Used to confirm Graves&#39; disease, but not the initial test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Anti-Thyroglobulin Antibody:</span></strong><span style=\"font-size:12.0pt\"> More specific for Hashimoto&#39;s thyroiditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Anti-thyroid peroxidase antibody:</span></strong><span style=\"font-size:12.0pt\"> Also used in autoimmune thyroid diseases but not the first-line test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ultrasensitive TSH is the first-line test in evaluating thyroid disorders.</span></span></span></p>",
      "correct_choice_id": 236479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59474,
      "choices": [
        {
          "id": 237209,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reassurance</span></span></span></p>"
        },
        {
          "id": 237210,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Surgical excision</span></span></span></p>"
        },
        {
          "id": 237211,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chemotherapy</span></span></span></p>"
        },
        {
          "id": 237212,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radiotherapy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is the treatment of choice for Meningioma? (FMGE DEC 2021)</span></span></span></p>",
      "unique_key": "Q9066107",
      "question_audio": null,
      "question_video": null,
      "map_id": 35893245,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Surgical excision</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Meningiomas are typically benign tumors arising from the meninges. The primary treatment for symptomatic or growing meningiomas is surgical excision. Surgery aims to completely remove the tumor, which can often lead to a cure, especially if the tumor is benign and accessible.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Meningiomas are categorized into three grades:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Grade 1 Meningioma</span></strong><span style=\"font-size:12.0pt\">: This is a benign tumor. The treatment of choice is surgical excision, and adjunctive radiation therapy is not typically required for this grade.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Grade 2 Meningioma</span></strong><span style=\"font-size:12.0pt\">: This type is atypical and falls between benign and malignant. For grade 2 meningiomas, surgery is the primary treatment. Radiation therapy may be necessary if the resection is incomplete or if there is residual disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Grade 3 Meningioma</span></strong><span style=\"font-size:12.0pt\">: This is a malignant tumor. Surgical excision is still the primary treatment; however, adjunctive radiation therapy is required in all cases due to the high risk of recurrence and the aggressive nature of the tumor.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In all 3 grades, the treatment of choice of meningiomas is surgical excision. The need for radiation therapy depends on the tumor grade and the completeness of the surgical resection. For tumors in locations where surgery is not feasible, radiotherapy becomes the preferred option.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Reassurance</span></strong><span style=\"font-size:12.0pt\">: Not appropriate for symptomatic or growing meningiomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chemotherapy</span></strong><span style=\"font-size:12.0pt\">: Generally not effective for benign meningiomas and is not a standard treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Radiotherapy</span></strong><span style=\"font-size:12.0pt\">: Used as an adjunct treatment if the tumor is inoperable or recurs but is not the first-line treatment for resectable tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Surgical excision is the treatment of choice for symptomatic or growing meningiomas.</span></span></span></p>",
      "correct_choice_id": 237210,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54287,
      "choices": [
        {
          "id": 216617,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular tachycardia</span></p>"
        },
        {
          "id": 216618,
          "text": "<p><span style=\"font-size:12.0pt;\">Quadriparesis</span></p>"
        },
        {
          "id": 216619,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes insipidus</span></p>"
        },
        {
          "id": 216620,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebral edema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man was admitted to the hospital after three days of abdominal pain and vomiting. His laboratory reports revealed a potassium value of 3.2 mEq/L. All of the following can be seen except:</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8906926",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833750,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Cerebral edema</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient has hypokalemia, indicated by a potassium level of 3.2 mEq/L.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is not seen with <strong>Cerebral edema</strong>, which is typically associated with hyponatremia (low sodium levels) rather than hypokalemia. Hyponatremia can lead to an osmotic imbalance, causing water to move into brain cells and resulting in cerebral edema. This is not a recognized complication of hypokalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypokalemia can lead to several clinical manifestations:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ventricular tachycardia:</strong> Hypokalemia can cause ventricular arrhythmias, including ventricular tachycardia, due to its effect on cardiac electrical activity. Potassium is crucial for maintaining normal heart rhythm, and its deficiency can lead to dangerous arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Quadriparesis:</strong> Hypokalemia can cause muscle weakness and paralysis, including quadriparesis. It affects muscle function because potassium is essential for normal muscle cell function and nerve transmission. Severe hypokalemia can mimic conditions like Guillain-Barré syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diabetes insipidus:</strong> Hypokalemia can cause nephrogenic diabetes insipidus. This condition occurs due to a defect in the kidney's ability to respond to antidiuretic hormone (ADH), leading to excessive urination and thirst. Hypokalemia impairs the kidney's concentrating ability, contributing to this disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cerebral edema is not associated with hypokalemia; it is a complication of hyponatremia. Hypokalemia can cause ventricular arrhythmias, muscle weakness, and nephrogenic diabetes insipidus.</span></p>",
      "correct_choice_id": 216620,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54287/INI-CET_May_2024Medicine_Question_32.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54287/INI-CET_May_2024Medicine_Question_32.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47537,
      "choices": [
        {
          "id": 189759,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        },
        {
          "id": 189760,
          "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
        },
        {
          "id": 189761,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 189762,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old male presents with a fever. He is an intravenous drug user. On examination, a temperature of 38.5°C, and some spots can be noted over the fundus. CBC showed a leukocyte count of 20,000/cu mm. Blood has been sent for culture. Infective Endocarditis is suspected. How many minor Duke's Criteria are satisfied for the diagnosis? (</span>FMGE July 2023)</p>",
      "unique_key": "Q7204410",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833767,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Duke's Criteria for the diagnosis of infective endocarditis include both major and minor criteria. In this case, the minor criteria that are satisfied include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Fever &gt; 38°C:&nbsp;</strong>The patient has a fever of 38.5°C.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Predisposing heart condition or intravenous drug use:&nbsp;</strong>The patient is an intravenous drug user.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Immunologic phenomena:&nbsp;</strong>The presence of spots over the fundus suggests Roth spots, which are a form of immunologic phenomenon.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The other minor criteria –</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Vascular phenomena</span></li><li><span style=\"font-size:12.0pt;\">Blood culture is positive, but not meeting major criteria.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1:&nbsp;</strong>Only fever would be counted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 2:&nbsp;</strong>Fever and IV drug use would be counted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 4:&nbsp;</strong>This would require additional minor criteria that are not mentioned in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information -</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Duke’s Major criteria for IE –</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Blood culture persistently positive for typical microorganism ( ≥3 blood culture) from different puncture sides and gap between first and last culture should be atleast 1 hour: for diagnosis 2 out of 3 culture should be positive and for the same organism. Except Q fever -Coxiella Brunetti only single culture is enough.</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;Imaging – Positive Echocardiogram – For IE specifically Transesophageal Echo – will show vegetation near the valves</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, three minor Duke's criteria are satisfied for the diagnosis of infective endocarditis: fever &gt; 38°C, intravenous drug use, and immunologic phenomena (Roth spots).</span></p>",
      "correct_choice_id": 189761,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49203,
      "choices": [
        {
          "id": 196383,
          "text": "<p>The defective gene for adult type 1 disease is located on Chromosome 16</p>"
        },
        {
          "id": 196384,
          "text": "<p>The defective protein in the Autosomal Recessive type is Polycystin</p>"
        },
        {
          "id": 196385,
          "text": "<p>Adult type 1 disease is more common than adult type 2</p>"
        },
        {
          "id": 196386,
          "text": "<p>All of the above are true</p>"
        }
      ],
      "text": "<p>Which of the following statements about Polycystic Kidney Disease is incorrect? (NEET PG 2015)</p>",
      "unique_key": "Q7860656",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833755,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: B. The defective protein in the Autosomal Recessive type is Polycystin</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>The defective protein in Autosomal Recessive Polycystic Kidney Disease (ARPKD) is Fibrocystin, not Polycystin. ARPKD is associated with the PKHD1 gene that encodes Fibrocystin. This differs fundamentally from ADPKD, where PKD1 and PKD2 genes encode Polycystin 1 (PC1) and Polycystin 2 (PC2). The two forms of polycystic kidney disease have different genetic bases, clinical presentations, and ages of onset.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A</strong>. The defective gene for adult type 1 disease (ADPKD type 1) is located on Chromosome 16. This is the PKD1 gene that encodes Polycystin 1.</p><p>&nbsp;</p><p><strong>Option C</strong> . Adult type 1 disease (ADPKD type 1) is more common than adult type 2 disease (ADPKD type 2). PKD1 gene mutations account for approximately 85% of ADPKD cases, while PKD2 accounts for the remaining 15%.</p><p>&nbsp;</p><p><strong>Option D</strong> is incorrect because option B contains an error</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Autosomal dominant and recessive forms of polycystic kidney disease involve different genetic mutations affecting different proteins - ADPKD involves mutations in PKD1 or PKD2 genes encoding polycystins, while ARPKD involves mutations in PKHD1 gene encoding fibrocystin, with distinct clinical presentations and age of onset.</p>",
      "correct_choice_id": 196384,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84318,
      "choices": [
        {
          "id": 335848,
          "text": "<p>L4</p>"
        },
        {
          "id": 335849,
          "text": "<p>L5</p>"
        },
        {
          "id": 335850,
          "text": "<p>S1</p>"
        },
        {
          "id": 335851,
          "text": "<p>S4</p>"
        }
      ],
      "text": "<p>What is the root value associated with a normal plantar response?(NEET PG 2017)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>",
      "unique_key": "Q9895530",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833759,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. C) S1</strong></p><p>&nbsp;</p><p>The plantar response (plantar reflex) is a superficial reflex that involves the integrity of the S1 nerve root. When the lateral aspect of the sole of the foot is stimulated with a blunt object, the normal response (negative Babinski sign) is plantar flexion of the toes. This reflex is mediated by the S1 nerve root. The plantar reflex is an important part of the neurological examination, as an abnormal response (Babinski sign) indicates upper motor neuron pathology.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. L4</strong>: The L4 nerve root primarily mediates the patellar (knee) reflex, not the plantar response. L4 innervates the anterior thigh muscles and provides sensation to the medial leg.</p><p>&nbsp;</p><p><strong>Option B. L5</strong>: The L5 nerve root innervates the dorsiflexors of the foot and provides sensation to the lateral leg and dorsum of the foot, but is not the primary root for the plantar reflex.</p><p>&nbsp;</p><p><strong>Option D. S4</strong>: The S4 nerve root is involved in innervation of the perineum and contributes to bowel and bladder function, not the plantar response.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>The normal plantar response (plantar flexion of the toes) is mediated by the S1 nerve root, which is an important component of testing lower motor neuron integrity during neurological examination.</p>",
      "correct_choice_id": 335850,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52310,
      "choices": [
        {
          "id": 208737,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyoscine</span></p>"
        },
        {
          "id": 208738,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzhexol</span></p>"
        },
        {
          "id": 208739,
          "text": "<p><span style=\"font-size:12.0pt;\">Levodopa</span></p>"
        },
        {
          "id": 208740,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyproheptadine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient was treated with repeated doses of IV anti-emetic for severe vomiting. The patient now does not have vomiting but developed abnormal movements. What is the most appropriate treatment?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2021)</span></p>",
      "unique_key": "Q2521106",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833763,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Benzhexol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient likely received intravenous metoclopramide, a common anti-emetic, which can cause extrapyramidal side effects such as dystonia. Dystonia is a movement disorder characterized by involuntary muscle contractions, leading to repetitive movements or abnormal postures. This condition can be painful and distressing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The treatment of choice for drug-induced dystonia is an anticholinergic medication. Benzhexol (also known as trihexyphenidyl) is an anticholinergic drug that can effectively relieve dystonic reactions by blocking acetylcholine receptors in the central nervous system, thereby restoring the balance between dopamine and acetylcholine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hyoscine:</strong> Hyoscine (scopolamine) is primarily used to treat motion sickness and postoperative nausea. It is not effective for treating dystonia induced by anti-emetic medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Levodopa:</strong> Levodopa is used to treat Parkinson's disease by increasing dopamine levels in the brain. It is not appropriate for treating acute dystonic reactions caused by anti-emetic medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cyproheptadine:</strong> Cyproheptadine is an antihistamine with antiserotonergic and anticholinergic properties. While it can be used for some dystonic reactions, it is not the first-line treatment in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For patients who develop dystonic reactions after receiving anti-emetic medications like metoclopramide, the most appropriate treatment is an anticholinergic drug such as benzhexol (trihexyphenidyl). This helps alleviate the abnormal movements by restoring the balance between dopamine and acetylcholine in the central nervous system.</span></p>",
      "correct_choice_id": 208738,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74911,
      "choices": [
        {
          "id": 298541,
          "text": "<p><span style=\"font-size:16px;\">Protein C deficiency</span></p>"
        },
        {
          "id": 298542,
          "text": "<p><span style=\"font-size:16px;\">Prothrombin deficiency</span></p>"
        },
        {
          "id": 298543,
          "text": "<p><span style=\"font-size:16px;\">Factor V Leiden mutation</span></p>"
        },
        {
          "id": 298544,
          "text": "<p><span style=\"font-size:16px;\">Antithrombin III Deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">What is the most common cause of inherited Thrombophilia? (INICET NOV 2024)</span></p>",
      "unique_key": "Q8567603",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833746,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Factor V Leiden mutation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Factor V Leiden mutation is the <strong>most common inherited cause</strong> of thrombophilia. This genetic mutation makes <strong>Factor V resistant to inactivation by activated Protein C</strong>, leading to increased thrombotic risk. It is an autosomal dominant disorder and is particularly common in individuals of European descent.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Protein C deficiency:</strong> Less common than Factor V Leiden; leads to increased thrombotic risk</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Prothrombin deficiency:</strong> A rare inherited coagulation disorder that typically causes bleeding</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Antithrombin III deficiency:</strong> Relatively rare inherited thrombophilic condition</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Factor V Leiden mutation</strong> is the most common inherited cause of thrombophilia.</span></p>",
      "correct_choice_id": 298543,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74911/INI-CET_NOV_2024_Medicine_Q_-_36.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74911/INI-CET_NOV_2024_Medicine_Q_-_36.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16186,
      "choices": [
        {
          "id": 64704,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Insulinoma</span></span></span></p>"
        },
        {
          "id": 64705,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Somatostatinoma</span></span></span></p>"
        },
        {
          "id": 64706,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">VIPoma</span></span></span></p>"
        },
        {
          "id": 64707,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glucagonoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 49-year-old male presents with recurrent episodes of watery diarrhea, dehydration, hypokalemia, and achlorhydria. Which of the following neuroendocrine tumors can be responsible for these symptoms?</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (FMGE JAN 2023)</span></span></span></p>",
      "unique_key": "Q2318916",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833766,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>C) VIPoma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient&#39;s symptoms are indicative of <strong>WDHA syndrome (Watery Diarrhea, Hypokalemia, and Achlorhydria),</strong> which is characteristic of a <strong>VIPoma</strong>. VIPomas are rare neuroendocrine tumors that secrete vasoactive intestinal peptide (VIP), leading to the clinical features described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Insulinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Insulinomas typically present with hypoglycemia due to excessive insulin secretion, not with watery diarrhea or hypokalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Somatostatinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: These tumors can be non-functional or present with inhibitory syndrome, which includes hyperglycemia, cholelithiasis, and steatorrhea, but not with watery diarrhea and hypokalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Glucagonoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: These tumors present with hyperglycemia, diabetes, and a characteristic rash known as necrolytic migratory erythema (NME), rather than the symptoms described in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">VIPomas cause WDHA syndrome, characterized by watery diarrhea, hypokalemia, and achlorhydria.</span></span></span></p>",
      "correct_choice_id": 64706,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16180,
      "choices": [
        {
          "id": 64680,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI</span></p>"
        },
        {
          "id": 64681,
          "text": "<p><span style=\"font-size:12.0pt;\">Ultrasonogram</span></p>"
        },
        {
          "id": 64682,
          "text": "<p><span style=\"font-size:12.0pt;\">Sestamibi scan</span></p>"
        },
        {
          "id": 64683,
          "text": "<p><span style=\"font-size:12.0pt;\">CT scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman presented with complaints of bone pain and abdominal cramps. Her family says she has a history of abnormal behavior. The consultant doctor arrived at a provisional diagnosis based on the clinical features. Which of the following would be the best test to arrive at a definitive diagnosis? (FMGE JAN 2023)</span></p>",
      "unique_key": "Q6684603",
      "question_audio": null,
      "question_video": null,
      "map_id": 35893247,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C) Sestamibi scan</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of bone pain, abdominal cramps, and a history of abnormal behavior are indicative of primary hyperparathyroidism. This condition is often described by the <strong>phrase \"stones, bones, groans, and moans,\"</strong> referring to kidney stones, bone pain, abdominal symptoms, and psychological manifestations, respectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Primary hyperparathyroidism is most commonly caused by a parathyroid adenoma or hyperplasia. To localize the abnormal parathyroid gland(s), the <strong>Sestamibi scan is the best diagnostic test</strong>. This nuclear medicine scan uses a radiotracer that is absorbed by overactive parathyroid tissue, allowing for accurate localization.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#1f1f1f;font-size:12.0pt;\">Technetium-99m scan but,&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Sestamibi scan is better</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. MRI:</strong> While useful for imaging soft tissues, it is not the best choice for localizing hyperparathyroid tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ultrasonogram:</strong> Can help in identifying enlarged parathyroid glands but is less sensitive and specific compared to the Sestamibi scan.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CT scan:</strong> Useful for detailed imaging of various structures but not the best for identifying hyperparathyroid tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Sestamibi scan is the best diagnostic test for localizing abnormal parathyroid glands in primary hyperparathyroidism</span></p>",
      "correct_choice_id": 64682,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84314,
      "choices": [
        {
          "id": 335832,
          "text": "<p><span style=\"font-size:12.0pt;\">Subcutaneous LMWH</span></p>"
        },
        {
          "id": 335833,
          "text": "<p><span style=\"font-size:12.0pt;\">Steroids</span></p>"
        },
        {
          "id": 335834,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
        },
        {
          "id": 335835,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal saline / Dextrose</span></p>"
        }
      ],
      "text": "<p>A patient with traumatic paraplegia due to injury at the thoracic cord level of T3 is found to have a blood pressure of 210/120 mm Hg. What should be the initial management? (NEET PG 2016)</p>",
      "unique_key": "Q1535962",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833757,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. C) Nifedipine</strong></p><p>&nbsp;</p><p>This patient is exhibiting <strong>autonomic dysreflexia</strong>, a life-threatening emergency seen in patients with spinal cord injuries at or above T6. The T3 level injury in this patient has disrupted descending inhibitory pathways that normally regulate sympathetic outflow. When a noxious stimulus occurs below the level of injury (often bladder distention, bowel impaction, or skin irritation), there is massive sympathetic discharge resulting in severe hypertension. Immediate blood pressure control with a rapidly-acting antihypertensive agent like nifedipine is essential to prevent complications such as stroke, seizures, or myocardial infarction.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Subcutaneous LMWH</strong>: While deep venous thrombosis prophylaxis is important in spinal cord injury patients, LMWH does not address the immediate life-threatening hypertension from autonomic dysreflexia.</p><p>&nbsp;</p><p><strong>Option B. Steroids</strong>: Steroids have no role in the acute management of autonomic dysreflexia. They were previously used in acute spinal cord injury but are not indicated for this hypertensive emergency.</p><p>&nbsp;</p><p><strong>Option D. Normal saline/Dextrose</strong>: Intravenous fluids would not help and may worsen hypertension in autonomic dysreflexia. Blood pressure reduction, not volume expansion, is the priority.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Autonomic dysreflexia is a medical emergency in patients with spinal cord injuries at or above T6 requiring immediate blood pressure control with rapid-acting antihypertensives while simultaneously identifying and removing the triggering stimulus.</p>",
      "correct_choice_id": 335834,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74913,
      "choices": [
        {
          "id": 298549,
          "text": "<p><span style=\"font-size:16px;\">Modified Marsh classification</span></p>"
        },
        {
          "id": 298550,
          "text": "<p><span style=\"font-size:16px;\">IgA transglutaminase positivity</span></p>"
        },
        {
          "id": 298551,
          "text": "<p><span style=\"font-size:16px;\">IgG antigliadin positivity</span></p>"
        },
        {
          "id": 298552,
          "text": "<p><span style=\"font-size:16px;\">HLA DQ6 and HLA DQ11</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is not associated with celiac disease? (INICET NOV 2024)</span></p>",
      "unique_key": "Q7988841",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833748,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) HLA DQ6 and HLA DQ11</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Celiac disease is associated with specific HLA types – <strong>DQ2 (present in 95% of cases)</strong> and <strong>DQ8</strong>. HLA DQ6 and HLA DQ11 are <strong>not associated</strong> with celiac disease. The genetic predisposition to celiac disease is strongly linked to these specific HLA markers, which are essential for disease development.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Modified Marsh classification:</strong> Correct. Used for diagnosing celiac disease via endoscopic biopsies and to monitor improvement on a gluten-free diet.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. IgA transglutaminase positivity:</strong> Correct. Anti-tissue transglutaminase IgA (anti-tTG IgA) is the most reliable serologic test.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. IgG antigliadin positivity:</strong> Correct. Although less specific, it is useful especially in IgA-deficient patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Celiac disease is genetically associated with <strong>HLA-DQ2</strong> (95% of cases) and <strong>HLA-DQ8</strong>, not HLA-DQ6 and HLA-DQ11.</span></p>",
      "correct_choice_id": 298552,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74913/INI-CET_NOV_2024_Medicine_Q_-_38.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74913/INI-CET_NOV_2024_Medicine_Q_-_38.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54289,
      "choices": [
        {
          "id": 216625,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-Anion Gap Metabolic Acidosis (NAGMA)</span></p>"
        },
        {
          "id": 216626,
          "text": "<p><span style=\"font-size:12.0pt;\">High Anion Gap Metabolic Acidosis (HAGMA)</span></p>"
        },
        {
          "id": 216627,
          "text": "<p><span style=\"font-size:12.0pt;\">Compensated Metabolic Alkalosis</span></p>"
        },
        {
          "id": 216628,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory Acidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient arrives at the emergency department presenting with symptoms of abdominal pain, vomiting, tachypnea, and tachycardia. Laboratory results are as follows: pH: 7.34, Sodium: 135 mmol/L, Potassium: 5 mmol/L, Bicarbonate: 12 mmol/L, Chloride: 92 mmol/L, RBS: 450 mg/dL. Given these laboratory findings, which of the following statements best describes the patient's acid-base status?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3295743",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833752,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) High Anion Gap Metabolic Acidosis (HAGMA)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's clinical presentation and laboratory findings suggest diabetic ketoacidosis (DKA), a condition commonly seen in diabetes patients with high blood sugar levels (RBS: 450 mg/dL). The symptoms of abdominal pain, vomiting, tachypnea (rapid breathing), and tachycardia (rapid heart rate) are characteristic of DKA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The laboratory values indicate a metabolic acidosis:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>pH of 7.34</strong>: Slightly acidic, indicating acidosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Bicarbonate of 12 mmol/L</strong>: Low, consistent with metabolic acidosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Chloride of 92 mmol/L</strong>: Lower than normal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To determine the type of metabolic acidosis, we calculate the anion gap:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-125329.jpg\" alt=\"\" width=\"900\" height=\"66\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An anion gap greater than 12 mmol/L indicates a high anion gap metabolic acidosis (HAGMA). In this case, the anion gap is 31, confirming HAGMA.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">High anion gap metabolic acidosis is typically associated with conditions such as diabetic ketoacidosis, lactic acidosis, renal failure, and ingestion of toxins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Non-Anion Gap Metabolic Acidosis (NAGMA)</strong>: This occurs when the anion gap is normal (less than 12 mmol/L). Conditions that cause NAGMA include diarrhea and renal tubular acidosis. This does not match the patient's high anion gap.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Compensated Metabolic Alkalosis</strong>: This condition involves an elevated pH with high bicarbonate levels. The patient’s pH is acidic, not alkalotic, and bicarbonate is low.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Respiratory Acidosis</strong>: Characterized by a primary increase in carbon dioxide (CO2) levels leading to a low pH. The patient’s primary disturbance is metabolic, not respiratory.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">High anion gap metabolic acidosis (HAGMA) is characterized by an anion gap greater than 12 mmol/L, indicating an accumulation of unmeasured anions. This condition is often seen in diabetic ketoacidosis, which presents with elevated blood glucose levels and metabolic acidosis.</span></p>",
      "correct_choice_id": 216626,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54289/INI-CET_May_2024Medicine_Question_34.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54289/INI-CET_May_2024Medicine_Question_34.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74914,
      "choices": [
        {
          "id": 298553,
          "text": "<p><span style=\"font-size:16px;\">Glu → Val (6)</span></p>"
        },
        {
          "id": 298554,
          "text": "<p><span style=\"font-size:16px;\">Lys → Arg (9)</span></p>"
        },
        {
          "id": 298555,
          "text": "<p><span style=\"font-size:16px;\">Glu → Lys (6)</span></p>"
        },
        {
          "id": 298556,
          "text": "<p><span style=\"font-size:16px;\">Ala → Gly (9)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which mutation is seen in sickle cell disease? (INICET NOV 2024)</span></p>",
      "unique_key": "Q8220984",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833749,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Glu → Val (6)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Sickle cell disease is caused by a specific <strong>point mutation at position 6 of the β-globin chain</strong>, where <strong>glutamic acid (Glu)</strong> is replaced by <strong>valine (Val)</strong>. This single amino acid substitution leads to the formation of <strong>abnormal hemoglobin S (HbS)</strong>, which polymerizes under deoxygenated conditions, causing red blood cells to become sickle-shaped.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Sickle cell disease is caused by a point mutation at position 6 of the β-globin chain, where <strong>glutamic acid (Glu)</strong> is replaced by <strong>valine (Val)</strong>.</span></p>",
      "correct_choice_id": 298553,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74914/INI-CET_NOV_2024_Medicine_Q_-_39.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74914/INI-CET_NOV_2024_Medicine_Q_-_39.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11305,
      "choices": [
        {
          "id": 45186,
          "text": "<p><span style=\"font-size:12.0pt;\">Give antibiotics and send the patient home</span></p>"
        },
        {
          "id": 45187,
          "text": "<p><span style=\"font-size:12.0pt;\">Admit to ICU without mechanical ventilation</span></p>"
        },
        {
          "id": 45188,
          "text": "<p><span style=\"font-size:12.0pt;\">Admit to ICU with invasive mechanical ventilation</span></p>"
        },
        {
          "id": 45189,
          "text": "<p><span style=\"font-size:12.0pt;\">Consider admission in a non-ICU setting</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 68-year-old man presents with a cough with yellowish sputum. Auscultation revealed bronchial breath sounds. He is hemodynamically stable and not confused. On examination, his respiratory rate is 20/min and blood pressure is 110/70 mmHg. Lab reports show urea levels of 44 mg/dL. What is the next best step in the management of this patient?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2021)</span></p>",
      "unique_key": "Q3779065",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833762,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Consider admission in a non-ICU setting</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation suggests a lower respiratory tract infection, likely pneumonia, given the cough with yellow sputum and bronchial breath sounds on auscultation. The management decision can be guided by the <strong>CURB-65 score</strong>, which helps determine the severity of pneumonia and the need for hospitalization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The CURB-65 score components are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>C</strong>onfusion: No</span></li><li><span style=\"font-size:12.0pt;\"><strong>U</strong>rea &gt; 7 mmol/L (19 mg/dL): Yes (urea is 44 mg/dL)</span></li><li><span style=\"font-size:12.0pt;\"><strong>R</strong>espiratory rate ≥ 30/min: No (respiratory rate is 20/min)</span></li><li><span style=\"font-size:12.0pt;\"><strong>B</strong>lood pressure (systolic &lt; 90 mmHg or diastolic ≤ 60 mmHg): No (BP is 110/70 mmHg)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Age ≥ 65 years</strong>: Yes (patient is 68 years old)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient has two points (urea &gt; 19 mg/dL and age ≥ 65 years).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Based on the CURB-65 score:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>0 points</strong>: Outpatient treatment</span></li><li><span style=\"font-size:12.0pt;\"><strong>1 point</strong>: Consider outpatient treatment or short inpatient stay</span></li><li><span style=\"font-size:12.0pt;\"><strong>2 points</strong>: Inpatient treatment</span></li><li><span style=\"font-size:12.0pt;\"><strong>3-5 points</strong>: Consider ICU admission</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient scores 2 points, indicating the need for inpatient treatment but not necessarily in the ICU.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Give antibiotics and send the patient home:</strong> This would be appropriate for a patient with a CURB-65 score of 0 or possibly 1, but not for a score of 2, which indicates a higher risk that necessitates closer monitoring in an inpatient setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Admit to ICU without mechanical ventilation:</strong> ICU admission is generally reserved for patients with a CURB-65 score of 3 or higher, indicating severe pneumonia. This patient's condition does not meet those criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Admit to ICU with invasive mechanical ventilation:</strong> This is appropriate for patients with very severe pneumonia (CURB-65 score of 4-5) or those in respiratory distress, neither of which applies to this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For patients with pneumonia, the CURB-65 score is a useful tool for determining the appropriate level of care. A score of 2 typically indicates the need for inpatient treatment in a non-ICU setting.</span></p>",
      "correct_choice_id": 45189,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54290,
      "choices": [
        {
          "id": 216629,
          "text": "<p><span style=\"font-size:12.0pt;\">Fanconi syndrome presents with RTA 2</span></p>"
        },
        {
          "id": 216630,
          "text": "<p><span style=\"font-size:12.0pt;\">Bicarbonaturia is a feature of RTA 2</span></p>"
        },
        {
          "id": 216631,
          "text": "<p><span style=\"font-size:12.0pt;\">RTA 4 is associated with hypokalemia</span></p>"
        },
        {
          "id": 216632,
          "text": "<p><span style=\"font-size:12.0pt;\">RTA 4 is due to aldosterone resistance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Choose the incorrect statement about Renal Tubular Acidosis (RTA):</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7060886",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833753,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) RTA 4 is associated with hypokalemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Renal Tubular Acidosis (RTA) refers to a group of disorders characterized by defective renal acid-base regulation, leading to a normal anion gap metabolic acidosis. The main types of RTA include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>RTA Type 1 (Distal RTA):</strong> Characterized by a defect in the distal tubule's ability to secrete hydrogen ions, leading to acidosis and hypokalemia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>RTA Type 2 (Proximal RTA):</strong> Involves a defect in bicarbonate reabsorption in the proximal tubule, resulting in bicarbonaturia. Fanconi syndrome, a condition involving generalized proximal tubular dysfunction, often presents with RTA Type 2.</span></li><li><span style=\"font-size:12.0pt;\"><strong>RTA Type 4 (Hyperkalemic RTA):</strong> This type is associated with hypoaldosteronism or aldosterone resistance, leading to impaired potassium excretion and hyperkalemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fanconi syndrome presents with RTA 2:</strong> Correct. Fanconi syndrome often involves proximal RTA (Type 2), with features such as aminoaciduria, phosphaturia, glycosuria, and bicarbonaturia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Bicarbonaturia is a feature of RTA 2:</strong> Correct. Due to defective bicarbonate reabsorption in the proximal tubule, bicarbonaturia is a hallmark of Type 2 RTA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. RTA 4 is due to aldosterone resistance:</strong> Correct. Type 4 RTA is commonly due to aldosterone deficiency or resistance, leading to hyperkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">RTA Type 4 is characterized by hyperkalemia due to aldosterone deficiency or resistance. The incorrect statement is that RTA Type 4 is associated with hypokalemia, which contradicts the typical presentation of hyperkalemia in this type of RTA.</span></p>",
      "correct_choice_id": 216631,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54290/INI-CET_May_2024Medicine_Question_35.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54290/INI-CET_May_2024Medicine_Question_35.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74912,
      "choices": [
        {
          "id": 298545,
          "text": "<p><span style=\"font-size:16px;\">1, 3</span></p>"
        },
        {
          "id": 298546,
          "text": "<p><span style=\"font-size:16px;\">1, 4</span></p>"
        },
        {
          "id": 298547,
          "text": "<p><span style=\"font-size:16px;\">2, 3</span></p>"
        },
        {
          "id": 298548,
          "text": "<p><span style=\"font-size:16px;\">1, 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">In haemolytic anaemia, which of the following is correct? (INICET NOV 2024)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Urobilinogen is high</span></li><li><span style=\"font-size:16px;\">Serum conjugated bilirubin is elevated</span></li><li><span style=\"font-size:16px;\">Serum transaminases are increased</span></li><li><span style=\"font-size:16px;\">Indirect van den Bergh reaction is positive</span></li></ol>",
      "unique_key": "Q9460911",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833747,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) 1, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In haemolytic anaemia, there is increased destruction of red blood cells leading to elevated <strong>unconjugated (indirect) bilirubin</strong>. This results in:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>1. Urobilinogen is high:</strong> Increased <strong>urobilinogen</strong> in urine due to normal enterohepatic circulation</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>4. Indirect van den Bergh reaction is positive:&nbsp;</strong>Positive indirect van den Bergh reaction due to elevated unconjugated bilirubin</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">These findings are characteristic of haemolytic anaemia and help differentiate it from other causes of jaundice.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>2. Serum conjugated bilirubin is elevated:</strong> Incorrect, as conjugated bilirubin elevation is typically seen in obstructive jaundice or hepatic diseases, not in haemolytic anaemia</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>3. Serum transaminases are increased:</strong> Incorrect, as elevated transaminases indicate liver cell damage, which is not a feature of haemolytic anaemia</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Haemolytic anaemia is characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Increased urobilinogen in urine</span></li><li><span style=\"font-size:16px;\">Elevated unconjugated (indirect) bilirubin</span></li><li><span style=\"font-size:16px;\">Positive indirect van den Bergh reaction</span></li><li><span style=\"font-size:16px;\">Normal enterohepatic circulation</span></li></ul>",
      "correct_choice_id": 298546,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74912/INI-CET_NOV_2024_Medicine_Q_-_37.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74912/INI-CET_NOV_2024_Medicine_Q_-_37.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92174,
      "choices": [
        {
          "id": 367012,
          "text": "<p><span style=\"font-size:14.0pt;\">a, b, c</span></p>"
        },
        {
          "id": 367013,
          "text": "<p><span style=\"font-size:14.0pt;\">a, b, d</span></p>"
        },
        {
          "id": 367014,
          "text": "<p><span style=\"font-size:14.0pt;\">a, c, d</span></p>"
        },
        {
          "id": 367015,
          "text": "<p><span style=\"font-size:14.0pt;\">b, c, d</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following antimalarial drugs are commonly used for the clinical cure of malaria? (INICET MAY 2025)</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:14.0pt;\">Artemisinin</span></li><li><span style=\"font-size:14.0pt;\">Sulfadoxine-pyrimethamine</span></li><li><span style=\"font-size:14.0pt;\">Chloroquine</span></li><li><span style=\"font-size:14.0pt;\">Primaquine</span></li></ol>",
      "unique_key": "Q1645441",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833745,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) a, b, c</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clinical cure of malaria refers to achieving resolution of fever and clinical symptoms, which is different from radical cure that eliminates all parasite forms including gametocytes.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>a. Artemisinin:</strong> Correct for clinical cure Artemisinin and its derivatives are highly effective blood schizonticides that rapidly clear parasitemia and resolve clinical symptoms. They form the backbone of ACT (Artemisinin Combination Therapy), which is the WHO-recommended first-line treatment. A common example is ARTSP (artesunate with sulfadoxine-pyrimethamine), demonstrating how artemisinin is combined with other clinical cure agents for enhanced efficacy. These drugs are safe in G6PD deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>b. Sulfadoxine-pyrimethamine:</strong> Correct for clinical cure This combination effectively clears blood-stage parasites by inhibiting folate synthesis. It's frequently used as part of combination therapy for clinical cure, particularly in ACT regimens like ARTSP (with artesunate). It successfully eliminates parasitemia and resolves symptoms while being safe for patients with G6PD deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>c. Chloroquine:</strong> Correct for clinical cure Chloroquine remains effective for clinical cure of uncomplicated vivax malaria in areas without resistance. It acts as a blood schizonticide, clearing parasites from the bloodstream and resolving clinical symptoms. Despite P. falciparum resistance in many regions, it continues to be valuable for treating other Plasmodium species and is safe in G6PD deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>d. Primaquine:</strong> Not for clinical cure Primaquine serves a distinctly different purpose - it's used specifically for radical cure to eliminate hypnozoites (dormant liver stages) and gametocytes, particularly in P. vivax and P. ovale infections. While essential for preventing relapses, it's not used for achieving clinical cure of acute symptoms. Importantly, primaquine is contraindicated in G6PD deficiency due to risk of hemolysis, unlike the clinical cure drugs which are generally safe in these patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clinical cure of malaria is achieved with artemisinin, sulfadoxine-pyrimethamine, and chloroquine, while primaquine is reserved for radical cure and is contraindicated in G6PD deficiency.</span></p>",
      "correct_choice_id": 367012,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92174/INI_CET_May_2025_Medicine_Q_-_30.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92174/INI_CET_May_2025_Medicine_Q_-_30.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47667,
      "choices": [
        {
          "id": 190279,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lemon juice</span></span></span></span></p>"
        },
        {
          "id": 190280,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amla juice</span></span></span></span></p>"
        },
        {
          "id": 190281,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tea</span></span></span></span></p>"
        },
        {
          "id": 190282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sprouts</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following, when consumed with oral iron, reduces its absorption?</span></span></span></span></p>",
      "unique_key": "Q5406496",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833768,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Tea</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The absorption of oral iron can be affected by various dietary substances. Tea contains tannins, which are polyphenolic compounds that can bind to iron and reduce its absorption in the gastrointestinal tract. This is why tea consumption is often advised to be separated from iron supplementation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Lemon juice</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Contains high amounts of vitamin C (ascorbic acid), which actually enhances iron absorption by reducing ferric iron to the more absorbable ferrous form.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Amla juice</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Like lemon juice, it is rich in vitamin C and thus enhances iron absorption.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sprouts</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Contain iron and proteins, which can aid in iron absorption.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tea, due to its tannin content, can reduce the absorption of oral iron when consumed together.</span></span></span></span></p>",
      "correct_choice_id": 190281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59294,
      "choices": [
        {
          "id": 236489,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Creutzfeldt-Jakob Disease</span></span></p>"
        },
        {
          "id": 236490,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alzheimer&#39;s disease</span></span></p>"
        },
        {
          "id": 236491,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Whipple disease</span></span></p>"
        },
        {
          "id": 236492,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vascular dementia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 72-year-old pilot presented to a neurologist with rapidly progressive dementia, myoclonus, ataxia, and visual disturbances. EEG showed periodic complexes. What is the most likely diagnosis? (FMGE JUNE 2022)</span></span></span></p>",
      "unique_key": "Q9283333",
      "question_audio": null,
      "question_video": null,
      "map_id": 35893246,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Creutzfeldt-Jakob Disease</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Creutzfeldt-Jakob Disease (CJD) is a prion disease characterized by rapidly progressive dementia, myoclonus, and periodic sharp wave complexes on EEG. It typically presents in older adults and is fatal within months.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Alzheimer&#39;s disease:</span></strong><span style=\"font-size:12.0pt\"> Progresses more slowly and does not show periodic EEG complexes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Whipple disease:</span></strong><span style=\"font-size:12.0pt\"> Rare and presents with different symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Vascular dementia:</span></strong><span style=\"font-size:12.0pt\"> Usually has a stepwise progression with stroke-like episodes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Creutzfeldt-Jakob Disease is characterized by rapidly progressive dementia, myoclonus, and periodic sharp wave complexes on EEG.</span></span></span></p>",
      "correct_choice_id": 236489,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84316,
      "choices": [
        {
          "id": 335840,
          "text": "<p>Subthalamus</p>"
        },
        {
          "id": 335841,
          "text": "<p>Globus pallidus</p>"
        },
        {
          "id": 335842,
          "text": "<p>Substantia nigra</p>"
        },
        {
          "id": 335843,
          "text": "<p>Striatum</p>"
        }
      ],
      "text": "<p>What part of the brain is primarily damaged in cases of chorea? (NEET PG 2016)</p>",
      "unique_key": "Q9679851",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833758,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. D) Striatum</strong></p><p>&nbsp;</p><p>Chorea is characterized by involuntary, rapid, irregular, and purposeless movements that flow from one body part to another. The primary pathological changes in chorea involve the striatum (caudate nucleus and putamen). In Huntington's disease, the most well-known cause of chorea, there is selective degeneration of medium spiny neurons in the striatum, with progressive atrophy of the caudate nucleus and putamen visible on neuroimaging. This striatal degeneration disrupts the normal inhibitory output to the globus pallidus, ultimately leading to disinhibition of the thalamus and excessive movement manifestations.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Subthalamus:</strong> While the subthalamic nucleus plays an important role in the basal ganglia circuitry and movement control, it is not the primary site of pathology in chorea. Damage to the subthalamic nucleus typically results in hemiballismus, which involves more violent, flinging movements than chorea.</p><p>&nbsp;</p><p><strong>Option B. Globus pallidus:</strong> The globus pallidus is affected secondarily in chorea due to altered inputs from the diseased striatum. Primary globus pallidus lesions more commonly result in parkinsonian features or dystonia rather than chorea.</p><p>&nbsp;</p><p><strong>Option C. Substantia nigra:</strong> The substantia nigra is the primary site of degeneration in Parkinson's disease, leading to dopamine deficiency and hypokinetic movement disorders. It is not the primary site of pathology in choretic disorders.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Chorea primarily results from pathology in the striatum (caudate nucleus and putamen), which disrupts the normal basal ganglia circuitry and leads to disinhibition of thalamic nuclei, resulting in the characteristic random, flowing involuntary movements.</p>",
      "correct_choice_id": 335843,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56213,
      "choices": [
        {
          "id": 224269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">High HDV viral load</span></span></span></p>"
        },
        {
          "id": 224270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Presence of Anti-HBc IgM antibodies</span></span></span></p>"
        },
        {
          "id": 224271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Presence of IgM anti-HDV antibodies</span></span></span></p>"
        },
        {
          "id": 224272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Presence of Anti-HBc IgG antibodies</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serologic findings of a patient with hepatitis are given below. HBsAg positive, Anti-HBc (total) positive, Anti-HDV (total) positive. Which of the following is most useful in diagnosing HDV co-infection over superinfection?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q5486419",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833754,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Presence of Anti-HBc IgM antibodies</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To differentiate between HDV co-infection and superinfection, it is essential to understand the nature of these infections:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Co-infection&nbsp;</span></strong><span style=\"font-size:12.0pt\">occurs when a patient acquires both acute HBV and acute HDV simultaneously. The presence of <strong>Anti-HBc IgM antibodies</strong> indicates a recent acute HBV infection, which is characteristic of co-infection.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Superinfection&nbsp;</span></strong><span style=\"font-size:12.0pt\">occurs when a patient with chronic HBV infection acquires an acute HDV infection. In this scenario, the patient has markers of chronic HBV (like <strong>Anti-HBc IgG</strong> <strong>antibodies</strong>) along with markers of acute HDV infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Anti-HBc IgM antibodies</strong> are indicative of an acute HBV infection and are useful for diagnosing co-infection because they show that the HBV infection is recent, which aligns with the scenario of both HBV and HDV being acquired simultaneously.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>High HDV viral load</strong>: This can be present in both co-infection and superinfection and does not specifically differentiate between the two.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Presence of IgM anti-HDV antibodies</strong>: These antibodies can be present in both co-infection and superinfection as they indicate an acute HDV infection. Therefore, they are not useful in differentiating between the two conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Presence of Anti-HBc IgG antibodies</strong>: This indicates a past or chronic HBV infection. The presence of Anti-HBc IgG is more consistent with superinfection rather than co-infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of Anti-HBc IgM antibodies is most useful in diagnosing HDV co-infection over superinfection because it indicates a recent acute HBV infection, which is characteristic of co-infection.</span></span></span></p>",
      "correct_choice_id": 224270,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11225,
      "choices": [
        {
          "id": 44866,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tenofovir</span></span></span></span></p>"
        },
        {
          "id": 44867,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abacavir</span></span></span></span></p>"
        },
        {
          "id": 44868,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamivudine</span></span></span></span></p>"
        },
        {
          "id": 44869,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emtricitabine</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following antiretroviral drugs is not used in HIV &amp; hepatitis B co-infection?</span></span> <span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q9047026",
      "question_audio": null,
      "question_video": null,
      "map_id": 35833761,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Abacavir</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HLA B 57:01 mutation is associated with hypersensitivity to abacavir.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abacavir is used in PLHIV with renal failure however is not effective against HBV.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A, C, D&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">inhibit both HIV reverse transcriptase and HBV DNA polymerase, thereby, inhibiting their replication.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M184V mutation results in resistance to Lamivudine, emtricitabine.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, increases susceptibility to tenofovir, zidovudine and also reduces rate of viral replication (Beneficial). Hence addition of boosted protease inhibitor + lamivudine is continued in such cases.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the treatment of patients with HIV and hepatitis B co-infection, abacavir is not used due to its lack of efficacy against HBV. Instead, drugs like tenofovir, lamivudine, and emtricitabine, which have dual activity against both viruses, are preferred.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference: NACO 2021 HIV Care and treatment guidelines</span></span></strong></p>",
      "correct_choice_id": 44867,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}